The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Detection and Prevalence of Active Drug Efflux Mechanism in Various Multidrug-Resistant Klebsiella pneumoniae Strains from Turkey
Open accessAbstract
The prevalence of active drug efflux pump and porin alterations was investigated in Turkish nosocomial strains of Klebsiella pneumoniae exhibiting a multidrug-resistant phenotype. MICs of various antibiotics, including quinolones, chloramphenicol, tetracycline, and β-lactams, for those strains were determined either with or without the efflux pump inhibitor phenylalanine arginine β-naphthylamide (PAβN). Thirty-nine percent of the strains exhibited a PAβN-modulated resistance for quinolones, chloramphenicol, and tetracycline. In these strains, a significant increase of chloramphenicol accumulation was gained in the presence of the efflux pump inhibitor PAβN or with the energy uncoupler carbonyl cyanide m -chlorophenylhydrazone. Moreover, high-level expression of the membrane fusion protein AcrA, which was immunodetected in most of those isolates, suggests that the AcrAB/TolC efflux machinery contributed to their antibiotic resistance. Studies of K. pneumoniae porins indicated that the majority of the strains, including extended-spectrum β-lactamase producers and efflux-positive ones, presented an alteration in their sorbitol-sensitive porin (OmpK35) expression. This is the first report showing the prominent role of active drug efflux in the antibiotic resistance of nosocomial K. pneumoniae strains from Turkey.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This alteration in the type of porin expressed correlated with a 4 – 8 fold decrease in susceptibility for a wide range of β-lactam antimicrobials (41,42).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [41]
In the citing paper
“The post-therapy isolates were found to exhibit a shift in porin expression from OmpK35 to OmpK36 (the latter possessing a smaller channel size).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Jarlier, V., Nicolas-Chanoine, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,561
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542
Proton-dependent multidrug efflux systems
Paulsen, I. T., Brown, M. H., & Skurray, R. A. (1996) · Microbiological Reviews · doi:10.1128/mr.60.4.575-608.1996 · Cited by 1,089
Lomovskaya, O., Warren, M. S., Lee, A. Y., Galazzo, J. L., Fronko, R. M., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 403
The mar regulon: multiple resistance to antibiotics and other toxic chemicals
Alekshun, M. N., & Levy, S. B. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01589-9 · Cited by 399
Antibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
Nikaido, H. (2001) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2000.0247 · Cited by 319
Porin expression in clinical isolates of Klebsiella pneumoniae
Hernández-Allés, S., Albertí, S., Álvarez, D., Doménech‐Sánchez, A., Martı́nez-Martı́nez, L., Gil, J., Tomás, J. M., & Benedi, V. J. (1999) · Microbiology · doi:10.1099/13500872-145-3-673 · Cited by 192
Cited by
Sorted by citations
Items 101–131 of 131
Ashwath, P., & Sannejal, A. D. (2021) · Journal of Health and Allied Sciences NU · doi:10.1055/s-0041-1731914 · Cited by 7
Synergism between Outer Membrane Proteins and Antimicrobials
Veiga‐Crespo, P., Fusté, E., Vinuesa, T., Viñas, M., & Villa, T. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01786-10 · Cited by 7
Mechanisms of antibacterial drug resistance and approaches to overcome
Valsamatzi-Panagiotou, A., Traykovska, M., & Prof. Robert Penchovsky, D. R. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00002-3 · Cited by 7
Multidrug Effl ux Pumps: Structure, Mechanism, and Inhibition
Wax, R. G., Lewis, K., Salyers, A. A., & Taber, H. W. (2007) · doi:10.1201/9781420008753-8 · Cited by 6
Nascimento, R. J., Frasão, B. S., Dias, T. S., do Nascimento, E. R., Tavares, L. S. B., Almeida, V. L., & Aquino, M. H. C. (2019) · Pesquisa Veterinária Brasileira · doi:10.1590/1678-5150-pvb-6004 · Cited by 5
Nath, S., Ramana, B. V., Chaudhury, A., & Kumar, A. (2013) · Asian Journal of Pharmaceutical and Clinical Research · Cited by 4
Öncel, B., Hasdemir, U. O., Aksu, B., & Pournaras, S. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2267895 · Cited by 4
Self-citationFarivar, A. S., Nowroozi, J., Eslami, G., Sabokbar, A., & Hashemi, A. (2017) · Cited by 4
Nanobiotics to tackle efflux-mediated resistance in bacterial pathogens
Thillai, B. D., Kini, S., & Deekshit, V. K. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2597220 · Cited by 4
Neog, N., Puzari, M., & Chetia, P. (2024) · Current Computer - Aided Drug Design · doi:10.2174/0115734099294294240311061115 · Cited by 3
Avcıoğlu, N. H., & Bilkay, I. S. (2016) · Asian Biomedicine · doi:10.5372/1905-7415.1001.463 · Cited by 3
Krishnappa, L. G., & Marie, M. A. M. (2014) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000004 · Cited by 3
Allen, M. E. V., Weng, Y., Bina, X. R., & Bina, J. E. (2025) · Infection and Immunity · doi:10.1128/iai.00301-25 · Cited by 2
Zakaria, N., Hasan, N. A., Dani, A. F. M., Sadikun, A., Ibrahim, F., Kamarulzaman, E. E., & Mohamad, S. M. (2017) · Malaysian Journal of Microbiology · doi:10.21161/mjm.99717 · Cited by 2
Nair, M. V., Umrao, A., Rao, G. A., & Rao, J. (2020) · Journal of Emerging Investigators · doi:10.59720/20-036 · Cited by 2
Mechanisms of Drug Efflux and Strategies to Overcome Them as a Way to Control Microbial Growth
de Miguel, T., Rama, J. L. R., Feijoo-Siota, L., Ageitos, J. M., & Viñas, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-28368-5_6 · Cited by 2
Zgurskaya, H. I., Lomovskaya, O., Lewis, K., & Bostian, K. A. (2007) · CRC Press eBooks · doi:10.1201/9781420008753.ch4 · Cited by 2
Khalid, T. W. B. M., & Ghaima, K. K. (2023) · Bionatura · doi:10.21931/rb/css/2023.08.02.73 · Cited by 2
Fang, T., Su, X., Wang, D., Jiang, X., Li, Y., Wang, J., & Liu, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1871995/v1 · Cited by 2
Bacterial antibiotic resistance by efflux pumps
Marchetti, L., Errecalde, J. O., & Mestorino, O. N. (2011) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · Cited by 1
Antibiotic Resistant Salmonella serovars isolated from Madhya Pradesh Jabalpur Region
Siddiquie, M. D., Mishra, R. P., Dubey, S., & Joshi, M. (2013) · Cited by 1
Marchetti, M., Errecalde, J. O., & Mestorino, N. (2011) · Analecta Veterinaria · Cited by 1
Multidrug resistance in pathogenic microorganisms
Upmanyu, N., & Malviya, V. N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819001-2.00016-4 · Cited by 1
Facing Antimicrobial Resistance in Gastrointestinal Bacteria
Hassing, R. J. (2016) · EUR Research Repository (Erasmus University Rotterdam)
Sagar, D. S. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i9.02
Miniaturization of a screening method to find novel inhibitors of E. coli efflux pumps
Kurvonen, S. (2019) · Työväentutkimus Vuosikirja
Development of CmeABC Efflux Pump- Based Intervention Strategies Against Campylobacter
Ensminger, A. L. (2006)
La proteïna TolC de "Klebsiella oxytoca"
Bernadó, A. F. (2006) · TDX (Tesis Doctorals en Xarxa)
Metadata
- Authors
- Hasdemir, U. O., Chevalier, J., Nordmann, P., & Pagès, J.-M.
- Affiliations
- Aix-Marseille Université (FR)
- Bicêtre Hospital (FR)
- Enveloppe Bactérienne, Perméabilité et Antibiotiques, EA 2197, IFR48, Faculté de Médecine, Université de la Mediterranée, Marseille
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2004-06
- Volume
- 42
- Issue
- 6
- Pages
- 2701-2706
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC427859
- OpenAlex
- W2151288894
- Cited by
- 131
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 16 · 2015: 2 · 2014: 9 · 2013: 7 · 2012: 2
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion, other-oa)
- Funders
- AstraZeneca
- European Society of Clinical Microbiology and Infectious Diseases
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Klebsiella pneumoniae, multidrug resistance, AcrAB-TolC efflux system, AcrA, OmpK35, PAβN, CCCP, quinolone resistance, chloramphenicol resistance, tetracycline resistance, beta-lactam resistance, hospital isolates, extended-spectrum beta-lactamase, Turkey
- MeSH terms
- Bacterial Outer Membrane Proteins, Bacterial Proteins, Carbonyl Cyanide m-Chlorophenyl Hydrazone, Chloramphenicol, Hydrolases, Klebsiella pneumoniae, Microbial Sensitivity Tests, Porins, Drug Resistance, Multiple, Bacterial, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
